3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
24 25 0 0 0 0 0 0 0999 V2000
-3.2293 2.1871 0.0234 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.1762 1.2401 0.0722 N 0 0 0 0 0 0 0 0 0 0 0 0
4.6456 1.1774 0.0393 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.5267 -1.9308 -0.0203 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7728 -1.2483 0.5070 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.2581 -1.1196 -0.0276 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1932 -0.1335 -0.4212 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.1393 0.2781 0.0295 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5350 1.1681 -0.0725 C 0 0 0 0 0 0 0 0 0 0 0 0
0.9274 -1.8915 -0.1092 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1563 0.8443 0.0591 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1940 -1.3123 -0.0962 C 0 0 0 0 0 0 0 0 0 0 0 0
2.3088 0.0630 -0.0035 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5982 0.6778 0.0201 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7062 -2.2979 -1.0394 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.3658 -2.8180 0.6076 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.5766 -1.9937 0.5474 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.6187 -0.8863 1.5308 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.2757 0.0149 -0.3188 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.9994 -0.3625 -1.4749 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.8495 2.1928 0.2223 H 0 0 0 0 0 0 0 0 0 0 0 0
0.8622 -2.9769 -0.1747 H 0 0 0 0 0 0 0 0 0 0 0 0
1.2661 1.9281 0.1193 H 0 0 0 0 0 0 0 0 0 0 0 0
3.0724 -1.9497 -0.1536 H 0 0 0 0 0 0 0 0 0 0 0 0
1 9 2 0 0 0 0
2 8 1 0 0 0 0
2 9 1 0 0 0 0
2 21 1 0 0 0 0
3 14 3 0 0 0 0
4 5 1 0 0 0 0
4 6 1 0 0 0 0
4 15 1 0 0 0 0
4 16 1 0 0 0 0
5 7 1 0 0 0 0
5 17 1 0 0 0 0
5 18 1 0 0 0 0
6 8 2 0 0 0 0
6 10 1 0 0 0 0
7 9 1 0 0 0 0
7 19 1 0 0 0 0
7 20 1 0 0 0 0
8 11 1 0 0 0 0
10 12 2 0 0 0 0
10 22 1 0 0 0 0
11 13 2 0 0 0 0
11 23 1 0 0 0 0
12 13 1 0 0 0 0
12 24 1 0 0 0 0
13 14 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
2-oxo-1,3,4,5-tetrahydro-1-benzazepine-8-carbonitrile
4.2 InChl
InChI=1S/C11H10N2O/c12-7-8-4-5-9-2-1-3-11(14)13-10(9)6-8/h4-6H,1-3H2,(H,13,14)
4.3 InChlKey
FQVZGVGNHKZDED-UHFFFAOYSA-N
4.4 Canonical SMILES
C1CC2=C(C=C(C=C2)C#N)NC(=O)C1
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病